Horizon Therapeutics Public Limited Company - Ordinary Shares (HZNP) Social Stream
Horizon Therapeutics Public Ltd Co (HZNP) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Horizon Therapeutics Public Ltd Co.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 12 | $154.03 | $107 | $132.25 | $107.95 | 22.51% |
The Trend in the Analyst Price Target
HZNP's average price target has moved up $18.07 over the prior 90 days.
HZNP reports an average of 27.14% for its upside potential over the past 15 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-11 | 12 | 154.03 | 107 | 132.25 | 107.74 | 22.75% |
| 2021-09-04 | 11 | 141.00 | 107 | 130.27 | 110.01 | 18.42% |
| 2021-08-28 | 11 | 141.00 | 107 | 130.27 | 108.23 | 20.36% |
| 2021-08-14 | 11 | 141.00 | 96 | 126.36 | 106.72 | 18.4% |
| 2021-08-07 | 11 | 141.00 | 96 | 126.36 | 105.96 | 19.25% |
| 2021-08-05 | 10 | 141.00 | 96 | 124.60 | 106.37 | 17.14% |
| 2021-08-01 | 10 | 125.00 | 96 | 115.70 | 100.02 | 15.68% |
| 2021-07-24 | 10 | 125.00 | 88 | 114.90 | 101.05 | 13.71% |
| 2021-07-17 | 11 | 125.00 | 88 | 114.18 | 93.46 | 22.17% |
| 2021-07-10 | 11 | 125.00 | 88 | 114.18 | 95.28 | 19.84% |
| 2021-07-03 | 11 | 125.00 | 88 | 114.18 | 95.87 | 19.1% |
| 2021-06-26 | 11 | 125.00 | 88 | 114.18 | 95.92 | 19.04% |
| 2021-06-13 | 11 | 125.00 | 88 | 114.18 | 93.29 | 22.39% |
| 2021-06-05 | 11 | 125.00 | 88 | 114.18 | 89.25 | 27.93% |
| 2021-05-22 | 11 | 125.00 | 88 | 114.18 | 93.98 | 21.49% |
| 2021-05-15 | 11 | 125.00 | 88 | 114.18 | 92.14 | 23.92% |
| 2021-05-08 | 11 | 125.00 | 88 | 114.46 | 87.93 | 30.17% |
| 2021-04-25 | 11 | 125.00 | 88 | 114.00 | 94.63 | 20.47% |
| 2021-04-17 | 11 | 125.00 | 88 | 114.00 | 93.27 | 22.23% |
| 2021-04-10 | 11 | 125.00 | 88 | 114.00 | 91.48 | 24.62% |
| 2021-04-03 | 11 | 125.00 | 88 | 114.00 | 90.50 | 25.97% |
| 2021-03-20 | 10 | 125.00 | 88 | 114.60 | 89.58 | 27.93% |
| 2021-03-13 | 9 | 125.00 | 88 | 112.33 | 91.78 | 22.39% |
| 2021-03-06 | 8 | 125.00 | 88 | 113.00 | 88.65 | 27.47% |
| 2021-02-27 | 8 | 125.00 | 88 | 113.00 | 90.91 | 24.3% |
| 2021-02-20 | 9 | 125.00 | 83 | 107.78 | 88.87 | 21.28% |
| 2021-02-13 | 9 | 125.00 | 83 | 105.89 | 90.53 | 16.97% |
| 2021-02-06 | 9 | 125.00 | 83 | 105.78 | 85.22 | 24.13% |
| 2021-01-30 | 11 | 123.00 | 83 | 105.09 | 72.48 | 44.99% |
| 2021-01-23 | 11 | 123.00 | 81 | 104.82 | 77.73 | 34.85% |
| 2021-01-16 | 11 | 123.00 | 81 | 104.82 | 78.72 | 33.16% |
| 2021-01-09 | 12 | 123.00 | 47 | 100.00 | 79.54 | 25.72% |
| 2021-01-02 | 12 | 123.00 | 47 | 100.00 | 73.15 | 36.71% |
| 2020-12-26 | 12 | 123.00 | 47 | 100.00 | 68.92 | 45.1% |
| 2020-12-19 | 12 | 123.00 | 47 | 100.00 | 69.68 | 43.51% |
| 2020-12-09 | 12 | 123.00 | 47 | 100.67 | 70.10 | 43.61% |
| 2020-12-07 | 12 | 123.00 | 47 | 100.67 | 69.87 | 44.08% |
| 2020-11-28 | 12 | 123.00 | 47 | 100.67 | 70.55 | 42.69% |
| 2020-11-02 | 11 | 123.00 | 85 | 105.55 | 73.67 | 43.27% |
| 2020-10-21 | 11 | 123.00 | 80 | 102.27 | 74.27 | 37.7% |
| 2020-09-23 | 11 | 123.00 | 80 | 101.82 | 79.78 | 27.63% |
| 2020-09-08 | 11 | 123.00 | 80 | 100.91 | NA | NA% |
| 2020-08-26 | 10 | 123.00 | 80 | 100.00 | NA | NA% |
| 2020-08-17 | 9 | 123.00 | 80 | 98.67 | NA | NA% |
| 2020-08-07 | 9 | 123.00 | 80 | 98.33 | NA | NA% |
| 2020-07-22 | 9 | 90.00 | 42 | 63.56 | NA | NA% |
| 2020-07-15 | 9 | 66.00 | 42 | 56.78 | NA | NA% |
| 2020-06-22 | 9 | 63.00 | 42 | 54.22 | NA | NA% |
| 2020-06-05 | 9 | 61.00 | 42 | 53.33 | NA | NA% |
HZNP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 5 | 6 | 1 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
HZNP's average broker recommendation rating worsened by 0.09 over the prior 62 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- The average analyst price target of HZNP is greater than 88.76% of all US stocks.
- HZNP has a greater number of analysts covering the stock than 90.74% of Pharmaceutical Products stocks.
- HZNP has a higher upside potential (average analyst target price relative to current price) than 15.85% of Pharmaceutical Products stocks.
- Horizon Therapeutics Public Ltd Co's variance in analysts' estimates is less than 39.33% of all US stocks.
Stocks similar to Horizon Therapeutics Public Ltd Co in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ARVN, IGMS and BBIO.
Make investment decisions regarding HZNP using the data that counts. Try POWR Ratings for free.